Literature DB >> 33618668

Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.

Tianyi Gao1, Yingdong Gao1, Xiangxiang Liu2, Zhenlin Nie1, Huilin Sun2, Kang Lin1, Hongxin Peng1, Shukui Wang3,4,5.   

Abstract

BACKGROUND: A severe form of pneumonia, named coronavirus disease 2019 (COVID-19) by the World Health Organization is widespread on the whole world. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was proved to be the main agent of COVID-19. In the present study, we conducted an in depth analysis of the SARS-COV-2 nucleocapsid to identify potential targets that may allow identification of therapeutic targets.
METHODS: The SARS-COV-2 N protein subcellular localization and physicochemical property was analyzed by PSORT II Prediction and ProtParam tool. Then SOPMA tool and swiss-model was applied to analyze the structure of N protein. Next, the biological function was explored by mass spectrometry analysis and flow cytometry. At last, its potential phosphorylation sites were analyzed by NetPhos3.1 Server and PROVEAN PROTEIN.
RESULTS: SARS-COV-2 N protein composed of 419 aa, is a 45.6 kDa positively charged unstable hydrophobic protein. It has 91 and 49% similarity to SARS-CoV and MERS-CoV and is predicted to be predominantly a nuclear protein. It mainly contains random coil (55.13%) of which the tertiary structure was further determined with high reliability (95.76%). Cells transfected with SARS-COV-2 N protein usually show a G1/S phase block company with an increased expression of TUBA1C, TUBB6. At last, our analysis of SARS-COV-2 N protein predicted a total number of 12 phosphorylated sites and 9 potential protein kinases which would significantly affect SARS-COV-2 N protein function.
CONCLUSION: In this study, we report the physicochemical properties, subcellular localization, and biological function of SARS-COV-2 N protein. The 12 phosphorylated sites and 9 potential protein kinase sites in SARS-COV-2 N protein may serve as promising targets for drug discovery and development for of a recombinant virus vaccine.

Entities:  

Keywords:  Nucleocapsid protein (N protein); Phosphorylation; SARS-COV-2; Structure

Year:  2021        PMID: 33618668      PMCID: PMC7898026          DOI: 10.1186/s12866-021-02107-3

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


  2 in total

Review 1.  Minireview of progress in the structural study of SARS-CoV-2 proteins.

Authors:  Guoliang Zhu; Chunmei Zhu; Yun Zhu; Fei Sun
Journal:  Curr Res Microb Sci       Date:  2020-06-29

2.  Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle.

Authors:  Yingying Cong; Mustafa Ulasli; Hein Schepers; Mario Mauthe; Philip V'kovski; Franziska Kriegenburg; Volker Thiel; Cornelis A M de Haan; Fulvio Reggiori
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

  2 in total
  12 in total

Review 1.  The vital role of animal, marine, and microbial natural products against COVID-19.

Authors:  Aljawharah A Alqathama; Rizwan Ahmad; Ruba B Alsaedi; Raghad A Alghamdi; Ekram H Abkar; Rola H Alrehaly; Ashraf N Abdalla
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 2.  Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules.

Authors:  Chunye Zhang; Ming Yang
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

3.  Active site prediction of phosphorylated SARS-CoV-2 N-Protein using molecular simulation.

Authors:  Sreenidhi Sankararaman; John Hamre; Fahad Almsned; Abdulrhman Aljouie; Yahya Bokhari; Mohammed Alawwad; Lamya Alomair; M Saleet Jafri
Journal:  Inform Med Unlocked       Date:  2022-02-21

4.  Spread of endemic SARS-CoV-2 lineages in Russia before April 2021.

Authors:  Galya V Klink; Ksenia R Safina; Sofya K Garushyants; Mikhail Moldovan; Elena Nabieva; Andrey B Komissarov; Dmitry Lioznov; Georgii A Bazykin
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

5.  SARS-CoV-2 Nucleocapsid Protein Has DNA-Melting and Strand-Annealing Activities With Different Properties From SARS-CoV-2 Nsp13.

Authors:  Bo Zhang; Yan Xie; Zhaoling Lan; Dayu Li; Junjie Tian; Qintao Zhang; Hongji Tian; Jiali Yang; Xinnan Zhou; Shuyi Qiu; Keyu Lu; Yang Liu
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

6.  SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl- accumulation in respiratory epithelium.

Authors:  Lei Chen; Wei-Jie Guan; Zhuo-Er Qiu; Jian-Bang Xu; Xu Bai; Xiao-Chun Hou; Jing Sun; Su Qu; Ze-Xin Huang; Tian-Lun Lei; Zi-Yang Huang; Jincun Zhao; Yun-Xin Zhu; Ke-Nan Ye; Zhao-Rong Lun; Wen-Liang Zhou; Nan-Shan Zhong; Yi-Lin Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-07-27

Review 7.  An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.

Authors:  Arun Bahadur Gurung; Mohammad Ajmal Ali; Joongku Lee; Mohammad Abul Farah; Khalid Mashay Al-Anazi
Journal:  Biomed Res Int       Date:  2021-06-24       Impact factor: 3.411

8.  In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19.

Authors:  Athene Hoi-Ying Lam; Jian-Piao Cai; Ka-Yi Leung; Ricky-Ruiqi Zhang; Danlei Liu; Yujing Fan; Anthony Raymond Tam; Vincent Chi-Chung Cheng; Kelvin Kai-Wang To; Kwok-Yung Yuen; Ivan Fan-Ngai Hung; Kwok-Hung Chan
Journal:  Diagnostics (Basel)       Date:  2021-12-13

9.  Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19.

Authors:  Wajihul Hasan Khan; Nida Khan; Avinash Mishra; Surbhi Gupta; Vikrant Bansode; Deepa Mehta; Rahul Bhambure; M Ahmad Ansari; Shukla Das; Anurag S Rathore
Journal:  Int J Biol Macromol       Date:  2022-01-17       Impact factor: 6.953

Review 10.  SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines.

Authors:  Suresh Thakur; Shalitha Sasi; Sindhu Gopinathan Pillai; Ayantika Nag; Dhananjay Shukla; Ritu Singhal; Sameer Phalke; G S K Velu
Journal:  Front Med (Lausanne)       Date:  2022-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.